Background Preterm pre-labour ruptured membranes close to term is associated with increased risk of neonatal infection, but immediate delivery is associated with risks of prematurity. The balance of risks is unclear. We aimed to establish whether immediate birth in singleton pregnancies with ruptured membranes close to term reduces neonatal infection without increasing other morbidity.
Introduction
Pre-labour rupture of the membranes (ie, rupture of the membranes before the onset of labour) occurs in 20% of all births and 40% of all preterm births. 1 At term, there is good evidence that immediate delivery is associated with a lower incidence of maternal infection and increased maternal satisfaction compared with expectant manage ment, with no attendant risks of perinatal morbidity or mortality. 5 and recommended by the American College of Obstetricians and Gynecologists and Royal College of Obstetrics and Gynaecology on the basis of such conclusions as "at 34 0/7 weeks or greater gestation, delivery is recommended for all women with ruptured membranes", 7 and "delivery should be considered at 34 weeks of gestation". 8 These conclusions are despite the recognition that such recommend ations are "based on limited and inconsistent scientifi c evidence". 7 Therefore, unlike premature rupture of membranes at term, preterm premature rupture of membranes continues to pose a clinical dilemma. The risks of delay, such as placental abruption, ascending infection, intrapartum fetal distress, and cord prolapse, 9, 10 need to be balanced against the attendant risk of iatrogenic prematurity from immediate delivery. At extreme preterm gestations-when the fetus has reached or is close to viability (23-30 weeks gestation)-in the absence of established infection or maternal or fetal compromise, there is unanimity that expectant management is desirable 6 because preterm fetuses born before 30 weeks have an increased risk of neonatal mortality, intraventricular haemorrhage, hyaline membrane disease, and necrotising enterocolitis. However, these risks are reduced as the gestational age extends towards term. 11 Recommendations for immediate delivery after preterm pre-labour ruptured membranes close to term need to be backed up by good clinical evidence because even mild prematurity is associated with a substantial health burden, both in the short and long term. 12 We undertook the PPROMT trial-a pragmatic international multicentre randomised controlled trialto establish the optimum management of birth after preterm pre-labour rupture of the membranes close to term by comparing immediate delivery with expectant management.
Methods

Study design and participants
The study took place at 65 centres in 11 countries (Australia, New Zealand, Argentina, South Africa, Brazil, UK, Norway, Egypt, Uruguay, Poland, and Romania) between May 28, 2004 , and June 30, 2013 (appendix). The study protocol has been published previously. 13 All participating centres had the facilities to provide care for mothers and neonates born at 34 weeks, including the availability of respiratory support.
Eligible women were aged over 16 years with a singleton pregnancy and clinically suspected ruptured membranes between 34 weeks and 36 weeks and 6 days of gestation. Women who presented with ruptured membranes earlier in pregnancy became eligible on reaching 34 weeks of gestation. Exclusion criteria were established labour, chorioamnionitis, meconium staining, or any other contraindication to continuing the pregnancy. Group B streptococcus vaginal colonisation was not an exclusion criterion. Eligible women were identifi ed by a local research coordinator or clinical staff and provided with the trial information sheet, and, after written informed consent, entry details were recorded on a trial entry form.
The study was approved by the institutional ethics review boards of each clinical site and the data coordinating centre (Royal North Shore Hospital, St Leonards, NSW, Australia; North Sydney Local Health District 0902-032M; Site Specifi c Assessment: 0904-082M). All participants gave written informed consent before enrolment.
Randomisation and masking
Women were randomly assigned (1:1) to an experimental group in which birth was planned immediately (immediate delivery group) or a control group in which participants awaited spontaneous onset of labour or birth was planned at term or if other indications arose (expectant management group). Randomisation was done via a central telephone service using a computergenerated randomisation schedule prepared by a researcher not involved in treatment allocation, with balanced, variable blocks (sizes 2, 4, and 6), stratifi ed by centre. Masking to treatment allocation was not possible, but those adjudicating on the primary outcome of neonatal sepsis were masked to treatment allocation.
Procedures
Women in the immediate delivery group had delivery scheduled as close to randomisation as possible and preferably within 24 h. The mode of birth was identifi ed See Online for appendix by usual obstetric indications. For women randomly assigned to expectant management, birth occurred after spontaneous labour, at term, or when the attending clinician felt that birth was mandated according to usual indications. Because there is no gold standard treatment with regards to inpatient or outpatient management after preterm pre-labour rupture of membranes, women were managed according to local guidelines. Throughout the recruitment period, antibiotics were deemed best practice for treatment of preterm pre-labour ruptured membranes, 14 and these were prescribed according to local protocols. Laboratory testing and other management was per usual hospital practice. Placental histology was encouraged but not uniformly requested.
In patients for whom the time of day of random assignment or preterm pre-labour rupture of membranes was missing, the hours from preterm pre-labour rupture of membranes to randomisation was imputed as the diff erence in days, plus 9 h, which was the median for participants without missing data. Only cultures from vaginal swabs taken between preterm pre-labour rupture of membranes and randomisation were assessed and fi ndings of normal vaginal fl ora and lactobacilli were classifi ed as negative. All other patient characteristics were reported by the participants at trial entry or collected from medical records.
Outcomes
The primary outcome was the incidence of either defi nite or probable neonatal sepsis established by comprehensive review of the neonatal data by a central adjudication committee masked to treatment allocation.
Defi nite systemic neonatal sepsis was defi ned as a positive culture of a known pathogen from blood or cerebrospinal fl uid (CSF) for which the baby was treated with antibiotics for 5 or more days (or died before 5 days), and the presence of one or more clinical signs of infection. For organisms of low virulence or high likelihood of skin contamination of the blood culture, such as coagulase-negative Staphylococcus, both a positive blood culture and an abnormal full blood count or abnormal C-reactive protein were required. An abnormal full blood count consisted of abnormal white cell count lower than 5 × 10⁹ cells per L or more than 30 × 10⁹ cells per L, platelet count lower than 100 000 cells per mL, neutrophil count lower than 1·5 × 10⁹ cells per L or immature-to-total neutrophil count ratio greater than 0·2. 15, 16 A C-reactive protein concentration higher than 95 nmol/L (10 mg/L) was regarded as abnormal. 17, 18 Clinical signs of infection were respiratory distress (ie, requiring ventilation, con tinuous positive airway pressure, or supplemental oxygen for more than 1 h), apnoea, lethargy, abnormal level of consciousness, circulatory compromise (including hypotension, poor perfusion, need for inotropic support, or volume expansion), temperature instability (temp erature <36°C or ≥38°C), or a combination thereof.
Probable neonatal sepsis was defi ned as the presence of clinical signs for which the baby was treated with antibiotics for 5 or more days together with one or more of an abnormal full blood count; abnormal C-reactive protein; positive Group B streptococcus antigen on bladder tap urine, blood, or CSF; elevated CSF white cell count 5 (CSF white cell count >100 × 10⁶ cells per L); growth of a known virulent pathogen (eg, Group B streptococcus, Escherichia coli, or Listeria) from a surface swab; or a histological diagnosis of pneumonia in an early neonatal death. Data are mean (SD), number (%), or n/N (%). Some percentages do not add up to 100 because of rounding. PPROM=preterm pre-labour rupture of membranes. *Data missing for one patient in each group. †Data missing for one patient in the expectant management group. ‡Culture resulting from vaginal swab after PPROM and at or before randomisation. §Antibiotics at randomisation or in the preceding 48 h. ¶Data for route of administration missing for one patient in the immediate delivery group and one in the expectant management group. Prespecifi ed secondary infant outcomes were a composite neonatal morbidity and mortality indicator (sepsis, mechanical ventilation ≥24 h, stillbirth, or neonatal death); respiratory distress syndrome; perinatal mortality; pneumonia; any mechanical ventilation (ie, intermittent positive pressure ventilation, continuous positive airway pressure, or high frequency ventilation) and any mechanical ventilation for at least 24 h; duration of stay in a neonatal intensive or special care unit; duration of stay in hospital; birthweight; small for gestational age (<10th percentile size); Apgar score lower than 7 at 5 min; antibiotics in the fi rst 48 h; lumbar puncture; circulatory compromise needing arterial line, fl uid bolus, or inotropic support; and receiving breast milk at discharge, either as exclusive or mixed feeding. 13, 19 Neonatal outcomes were obtained from diagnoses reported by the attending clinician in the medical records and collected for 28 days or until discharge.
Secondary maternal outcomes were antepartum or intrapartum haemorrhage, antepartum or postpartum thrombosis, cord prolapse, postpartum treatment with antibiotics, intrapartum fever (pyrexia ≥38·5°C), postpartum haemorrhage (>1000 mL), mode of delivery, onset of labour, and duration of hospital stay (total days from randomisation to delivery and from delivery to discharge or transfer). 13, 19 Chorioamnionitis was a trial entry exclusion criteria, but this secondary outcome is reported among the women with expectant management. Placental swabs and histological samples were also collected if available.
Statistical analysis
A sample size of 1812 (ie, 906 patients per group) was necessary to detect a reduction in neonatal sepsis of 5% in the expectant management group compared with 2·5% in the immediate delivery group, with a two-sided 5% signifi cance level and a power of 80%. One interim analysis was done after 506 women had been recruited, before submission for further funding on Feb 25, 2010 , by the independent data monitoring committee who reviewed the fi ndings and recommended that the study continue. A diff erence of at least 3 SDs in an interim analysis of a major endpoint was needed to justify stopping the trial.
All analyses were by intention to treat. No participants were excluded from the primary intention-to-treat analysis for protocol violations. The primary outcome was calculated as event numbers and percentages by treatment allocation. Eff ect measures (relative risks [RRs]) were calculated with 95% CIs, with expectant management as the reference group. Comparison of mean birthweight was done using a t test. Comparisons of maternal and infant length of stay (in days) were done using non-parametric Wilcoxon Mann-Whitney tests. There was no imputation for missing outcome data. Participants with missing data were excluded from calculation of secondary outcomes, with the numbers missing reported by group.
Clinically meaningful criteria were specifi ed a priori for assessment of the adequacy of the randomisation, and whether adjusted analyses were needed. 19 These were (1) a diff erence of more than 15% between groups in the median duration from premature rupture of membranes to randomisation; and (2) more than a 3-day diff erence in median gestational age at randomisation. If either criteria were met, adjusted logistic regression would be needed. No adjustment to the level of statistical signifi cance was made for multiple comparisons.
Prespecifi ed subgroup analyses for the primary outcome of neonatal sepsis comprised time from preterm pre-labour rupture of membranes until randomisation (<48 h, ≥48 h), gestational week of preterm pre-labour rupture of membranes (<34 weeks, ≥34 weeks), vaginal swab culture result (Group B streptococcus, other abnormal fl ora), and antibiotic use at randomisation. 
Role of the funding source
The funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. JAP and CSA had full access to all the data in the study and JMM had fi nal responsibility for the decision to submit for publication.
Results
Between May 28, 2004 , and June 30, 2013, 1839 women were recruited into the PPROMT trial: 924 to the immediate delivery group and 915 to the expectant management group (fi gure 1). 13 women in the immediate delivery group did not receive the allocated intervention compared with one in the expectant management group. One woman was lost to follow-up in the immediate birth group and two women withdrew and one was lost to follow-up in the expectant management group. Therefore, the primary outcome was assessed for 1835 (>99%) neonates: 923 in the immediate delivery group and 912 in the expectant management group.
The baseline characteristics of the two groups were similar (table 1). The median gestational age at randomisation in each group was 247 days (IQR immediate delivery 241−252 days; expectant management 241−253 days) and the median time from ruptured membranes to randomisation was 30·4 h (IQR 10−76) in the immediate delivery group and 26·4 h (9−62; 13·4% lower) in the expectant management group, and so no adjusted analyses were done. Figure 2 shows the diff erence in time between randomisation and delivery for the two groups.
At the time of random assignment, 725 (79%) women assigned to immediate delivery had a swab collected and 186 (26%) isolated an abnormal organism, including Women randomly assigned to expectant management were more likely to deliver after the spontaneous onset of labour (p<0·0001) and deliver at a later gestation (p>0·0001) than those assigned to immediate delivery (table 2) . Six women randomly assigned to immediate delivery delivered after 37 weeks, including fi ve who were found not to have premature rupture of membranes after randomisation and one who self-discharged from the enrolling hospital and gave birth later.
The primary outcome of defi nite or probable neonatal sepsis occurred in 23 (2%) of the 923 neonates whose mothers were assigned to immediate delivery and 29 (3%) of 912 neonates whose mothers were assigned expectant management (RR 0·8, 95% CI 0·5-1·3; table 3). There was no signifi cant diff erence in the composite measure of neonatal morbidity and mortality (ie, sepsis, ventilation for at least 24 h, or perinatal death), which occurred in 73 (8%) of 923 neonates whose mothers were assigned to immediate delivery and 61 (7%) of 911 neonates whose mothers were managed expectantly (RR 1·2, 95% CI 0·9-1·6). However, neonates born after immediate delivery had signifi cantly lower birthweight (p<0·0001), increased risk of respiratory distress (RR 1·6, 95% CI 1·1-2·3) and mechanical ventilation (1·4, 1·0-1·8), and spent more time in neonatal intensive care units or special care nurseries (p<0·0001; table 3). All other secondary infant outcomes were non-signifi cant (table 3) .
Six deaths occurred, three in each group (table 3) . Among women randomly assigned to immediate delivery, the deaths were from sudden infant death syndrome (31 days of age), congenital abnormality (3 weeks of age), and fetal death at 35 weeks gestation associated with acute suppurative chorioamnionitis according to the autopsy report. Among women randomly assigned to expectant management, the deaths were from sudden infant death syndrome (5 weeks of age), a congenital abnormality (12 weeks of age), and one of unknown cause (24 h of age).
Compared with expectant management, immediate delivery was associated with a reduced likelihood of antepartum haemorrhage (27 of 239 (26%) women assigned to immediate delivery had caesarean delivery compared with 169 (19%) of those assigned to expectant management (RR 1·4, 95% CI 1·2-1·7). 56 (6%) neonates of women in the expectant management group were delivered because of chorioamnionitis after random assignment. All other secondary maternal and pregnancy outcomes were non-signifi cant (table 3) .
Compared with expectant management, immediate delivery had no eff ect on sepsis, regardless of the gestational age at preterm pre-labour rupture of membranes (p interaction =0·43), the duration of preterm pre-labour rupture of membranes (p interaction =0·07), or the use of antibiotics at the time of preterm pre-labour rupture of membranes (p interaction =0·64; table 4). For women assigned to immediate delivery, neonatal sepsis occurred in four of 186 (2%) neonates born to women who had a positive culture on their vaginal swab compared with nine of 192 (5%) neonates born to mothers with a positive culture and managed expectantly (RR 0·4, 95% CI 0·1-1·4; table 4). Similarly, neonatal sepsis did not diff er between groups for those women with Group B streptococcus at the time of random assignment (RR 0·9, 95% CI 0·2-4·5). Of women with Group B streptococcus isolated, all of those assigned to early planned birth and 87 (99%) of 88 assigned to expectant management received intravenous antibiotics before birth.
Discussion
The fi ndings of this trial show that for women with ruptured membranes between 34 weeks and 36 weeks and 6 days of gestation who were carrying a single fetus and who had no contraindication for expectant management, immediate delivery increased neonatal complications with 7, 8 we advocate that expectant management is preferred to immediate delivery in women with ruptured membranes close to term. Women need to be monitored because of the increased risk of antepartum haemorrhage and a greater likelihood of developing a fever. This is, to our knowledge, the largest study to compare these two forms of accepted management (panel). Older studies that included women with premature rupture of membranes at preterm gestations did not show any reduction in neonatal sepsis or diff erences in neonatal morbidity with expectant management versus immediate delivery, 3 and two underpowered studies with inclusion criteria similar to the PPROMT trial, which were published whilst the present study was ongoing, reported that immediate delivery did not reduce neonatal sepsis compared with expectant management. 20, 21 The investigators of these studies concluded that neither neonatal morbidity nor caesarean delivery were increased with immediate delivery compared with expectant management. The PPROMT trial is the most adequately powered study to show that immediate delivery does not reduce neonatal sepsis, but does increase the likelihood of several aspects of early neonatal morbidity, including respiratory distress syndrome, mechanical ventilation, and duration of stay in special care nurseries or neonatal intensive care units, and an increased likelihood of caesarean delivery. Conversely, expectant management resulted in a lengthier hospital stay for the mother because 688 (75%) of 912 were managed in hospital. Women managed expectantly have a greater incidence of antepartum haemorrhage and develop a fever requiring antibiotics. This is important information that care providers can discuss with women regarding best practice in this clinical situation. Furthermore, there are substantial implications for practice, and widespread adoption of expectant management after ruptured membranes close to term is likely to have substantial resource and economic benefi ts. We plan to assess the latter in diff erent international settings.
The adoption of the practice of immediate deliveryadvocated in recent guidelines 7, 8 -is predicated on the basis of the fact that disability-free survival after early birth is high. However, there is increasing concern about the risks of adverse outcomes for late preterm neonates, with fi ndings from studies showing an increased risk of neonatal morbidity, 22 re-admission to hospital in early childhood, 23 and academic diffi culties in children at school age compared with neonates born at term. 24 These risks are thought to be associated with both gestational age and biological factors associated with the preterm birth, including preterm pre-labour rupture of membranes. 25 Immediate delivery does not seem to improve outcomes in preterm neonates and might exacerbate the risks of prematurity, especially in the absence of labour and at earlier gestational ages. Although expectant management in a potentially hostile intrauterine environment should be avoided, in a mother who is healthy, with no evidence of clinical chorioamnionitis, expectant management provides an opportunity for spontaneous labour to develop and for adaptive changes to occur in the neonate, resulting in a decreased risk of neonatal respiratory illness. 26 For some neonates, expectant management might also result in delivery at a substantially older gestational age. These factors might, in turn, result in a decrease in neonatal morbidity, decreased separation of mother and baby, improved proportion of breastfeeding mothers, and a reduction in risk of adverse childhood outcomes.
The delivery of expectant management was not prespecifi ed in the PPROMT protocol, but was a pragmatic application of each hospital's current usual care. However, 73% of women were managed as inpatients, almost 90% received antibiotics before delivery, and about 40% were given antenatal steroids. Our fi ndings suggest that expectant management should include careful monitoring of fever or other signs of maternal infection, symptoms of chorioamnionitis, and antepartum haemorrhage. Jan 29, 2015) . We also searched reference lists of trials and other review articles identifi ed from this initial search and from our records. We identifi ed nine studies 3, 20, 21 that compared immediate planned birth with expectant management in women with ruptured membranes between 34 and 37 weeks. Of these, seven were from 20-30 years ago, 3 when the practices used in the peripartum period were diff erent and approaches to the use of antibiotics, corticosteroids for fetal lung maturation, and the ascertainment of pulmonary maturity through the use of lecithin:sphingomyelin ratio varied. Methods used in two more recent studies were representative of contemporary maternity practice. 20, 21 Findings from our meta-analysis of these studies suggested that immediate birth does not reduce neonatal sepsis, but neither study was adequately powered and thus the have limited applicability.
Interpretation
The present study is, to our knowledge, the largest so far to assess immediate birth with expectant management in women with singleton pregnancies who presented with ruptured membranes close to term. Our fi ndings show that immediate birth does not reduce neonatal sepsis, but does increase the likelihood of respiratory distress and mechanical ventilator support for the baby and caesarean section for the mother. There are some increased risks to the mother such that ongoing surveillance is needed. The results support the practice of expectant management in pregnant women with ruptured membranes close to term if there is no contraindication to extending the pregnancy.
In addition to its size, the strengths of the PPROMT trial include the fact that it was centrally randomised, had near-complete follow-up, and was done across a range of international settings. Although the study recruited over a 10-year period, there have not been major changes in management, making the results widely generalisable. Many of the previous studies that assessed management of ruptured membranes were small and done before the widespread implementation of maternal antibiotic use to prolong latency and reduce short-term morbidity, including neonatal infection, in this population.
14,27-32 The PPROMT trial results, together with the results of the recent PPROMEXIL studies, 20, 21 suggest expectant management provides benefi ts without incurring signifi cant risk of harms to the neonate. However, some groups of women will need delivery after expectant management if there are signs of infection. Contrary to fi ndings from a recent report, 33 we found that immediate delivery did not confer benefi t on the women in whom Group B streptococcus was isolated from the genital tract. Such risk factors should be investigated further to identify specifi c indications for which immediate delivery is appropriate by undertaking an individual patient data meta-analysis of all those who participated in PPROMT and PPROMEXIL.
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